{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:38:09Z","timestamp":1758814689425},"reference-count":89,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4809","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:03:10Z","timestamp":1558594990000},"source":"Crossref","is-referenced-by-count":3,"title":["Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines"],"prefix":"10.3892","author":[{"given":"Agata","family":"Olejniczak-K\u0119der","sequence":"first","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Szary\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Wro\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Siedlecka-Kroplewska","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Kmie\u0107","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, 80-211 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"key20200713185904_b1-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"key20200713185904_b2-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"key20200713185904_b3-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"key20200713185904_b4-ijo-55-01-0223","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.18632\/oncotarget.14230","article-title":"Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185904_b5-ijo-55-01-0223","first-page":"2973","article-title":"Links between cancer stem cells and epithelial-mesenchymal transition","volume":"8","author":"Wang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20200713185904_b6-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1101\/gad.277681.116","article-title":"Distinctive properties of metastasis-initiating cells","volume":"30","author":"Celi\u00e0-Terrassa","year":"2016","journal-title":"Genes Dev"},{"key":"key20200713185904_b7-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","article-title":"High drug attrition rates--where are we going wrong?","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"key20200713185904_b8-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ddtec.2017.03.002","article-title":"The production of 3D tumor spheroids for cancer drug discovery","volume":"23","author":"Sant","year":"2017","journal-title":"Drug Discov Today Technol"},{"key":"key20200713185904_b9-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.yexcr.2012.03.026","article-title":"Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system","volume":"318","author":"Karlsson","year":"2012","journal-title":"Exp Cell Res"},{"key":"key20200713185904_b10-ijo-55-01-0223","first-page":"599","article-title":"In vitro characterization of spheres derived from colorectal cancer cell lines","volume":"52","author":"Olejniczak","year":"2018","journal-title":"Int J Oncol"},{"key":"key20200713185904_b11-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: An overview on the tools and techniques used for their analysis","volume":"34","author":"Costa","year":"2016","journal-title":"Biotechnol Adv"},{"key":"key20200713185904_b12-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"e0146052","DOI":"10.1371\/journal.pone.0146052","article-title":"What do we learn from spheroid culture systems? Insights from tumorspheres derived from primary colon cancer tissue","volume":"11","author":"Qureshi-Baig","year":"2016","journal-title":"PLoS One"},{"key":"key20200713185904_b13-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/jcb.25527","article-title":"Cancer stem cells protect non-stem cells from anoikis: Bystander effects","volume":"117","author":"Kim","year":"2016","journal-title":"J Cell Biochem"},{"key":"key20200713185904_b14-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key20200713185904_b15-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.yexcr.2015.04.018","article-title":"Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment","volume":"335","author":"Islam","year":"2015","journal-title":"Exp Cell Res"},{"key":"key20200713185904_b16-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/stem.1035","article-title":"Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: Preclinical and clinical evidences","volume":"30","author":"Siddique","year":"2012","journal-title":"Stem Cells"},{"key":"key20200713185904_b17-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1073\/pnas.1118857109","article-title":"The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations","volume":"109","author":"Yan","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185904_b18-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1007\/s13277-016-5232-6","article-title":"Characterization of cancer stem cells from different grades of human colorectal cancer","volume":"37","author":"Manhas","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200713185904_b19-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2017.05.176","article-title":"Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480","volume":"490","author":"Butler","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713185904_b20-ijo-55-01-0223","first-page":"7653","article-title":"Therapeutic strategies against cancer stem cells in human colorectal cancer","volume":"14","author":"Szary\u0144ska","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200713185904_b21-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archinte.167.6.562","article-title":"Long-term aspirin use and mortality in women","volume":"167","author":"Chan","year":"2007","journal-title":"Arch Intern Med"},{"key":"key20200713185904_b22-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"key20200713185904_b23-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"key20200713185904_b24-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s13277-010-0078-9","article-title":"PI3-kinase\/Wnt association mediates COX-2\/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: Chemoprevention by diclofenac","volume":"31","author":"Kaur","year":"2010","journal-title":"Tumour Biol"},{"key":"key20200713185904_b25-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-15-1360","article-title":"Aspirin suppresses the acquisition of chemoresistance in breast cancer by disrupting an NFkappaB-IL6 signaling axis responsible for the generation of cancer stem cells","volume":"76","author":"Saha","year":"2016","journal-title":"Cancer Res"},{"key":"key20200713185904_b26-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1186\/s12885-015-1868-7","article-title":"A novel aspirin prodrug inhibits NF\u03baB activity and breast cancer stem cell properties","volume":"15","author":"Kastrati","year":"2015","journal-title":"BMC Cancer"},{"key":"key20200713185904_b27-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ijc.28381","article-title":"Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH\/HES1 and activating PPARG in colorectal cancer","volume":"134","author":"Moon","year":"2014","journal-title":"Int J Cancer"},{"key":"key20200713185904_b28-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18040752","article-title":"Recent advances in targeting the EGFR signaling pathway for the treatment of metastatic colorectal cancer","volume":"18","author":"Miyamoto","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20200713185904_b29-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.molonc.2014.05.003","article-title":"Acquired resistance to EGFR-targeted therapies in colorectal cancer","volume":"8","author":"Van Emburgh","year":"2014","journal-title":"Mol Oncol"},{"key":"key20200713185904_b30-ijo-55-01-0223","first-page":"383","article-title":"A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells","volume":"9","author":"Goel","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20200713185904_b31-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1159\/000485405","article-title":"Reduction of NANOG mediates the inhibitory effect of aspirin on tumor growth and stemness in colorectal cancer","volume":"44","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key20200713185904_b32-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/ol.2014.2211","article-title":"5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-\u03b4","volume":"8","author":"Mhaidat","year":"2014","journal-title":"Oncol Lett"},{"key":"key20200713185904_b33-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"e0188100","DOI":"10.1371\/journal.pone.0188100","article-title":"In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil","volume":"12","author":"Virgone-Carlotta","year":"2017","journal-title":"PLoS One"},{"key":"key20200713185904_b34-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molmed.2013.03.002","article-title":"CD95 in cancer: Tool or target?","volume":"19","author":"Martin-Villalba","year":"2013","journal-title":"Trends Mol Med"},{"key":"key20200713185904_b35-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature09075","article-title":"CD95 promotes tumour growth","volume":"465","author":"Chen","year":"2010","journal-title":"Nature"},{"key":"key20200713185904_b36-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/ijo.2017.4083","article-title":"FasR and FasL in colorectal cancer","volume":"51","author":"Szarynska","year":"2017","journal-title":"Int J Oncol"},{"key":"key20200713185904_b37-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1038\/ncomms6238","article-title":"CD95 and CD95L promote and protect cancer stem cells","volume":"5","author":"Ceppi","year":"2014","journal-title":"Nat Commun"},{"key":"key20200713185904_b38-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jmb.2016.02.027","article-title":"Mechanisms of selective autophagy in normal physiology and cancer","volume":"428","author":"Mancias","year":"2016","journal-title":"J Mol Biol"},{"key":"key20200713185904_b39-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/stem.1031","article-title":"Colorectal cancer stem cells","volume":"30","author":"Vaiopoulos","year":"2012","journal-title":"Stem Cells"},{"key":"key20200713185904_b40-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2147\/OTT.S140854","article-title":"Cancer cell dormancy: Mechanisms and implications of cancer recurrence and metastasis","volume":"10","author":"Gao","year":"2017","journal-title":"OncoTargets Ther"},{"key":"key20200713185904_b41-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/cas.12958","article-title":"To wake up cancer stem cells, or to let them sleep, that is the question","volume":"107","author":"Takeishi","year":"2016","journal-title":"Cancer Sci"},{"key":"key20200713185904_b42-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"key20200713185904_b43-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"key":"key20200713185904_b44-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"12042","DOI":"10.1038\/s41598-018-30525-3","article-title":"Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer","volume":"8","author":"Szary\u0144ska","year":"2018","journal-title":"Sci Rep"},{"key":"key20200713185904_b45-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: The promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"key20200713185904_b46-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"21754","DOI":"10.18632\/oncotarget.15567","article-title":"The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: Role of EGFR-RAS-FOXM1-\u03b2- catenin signaling axis","volume":"8","author":"Valverde","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185904_b47-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1038\/oncsis.2013.35","article-title":"Epigenetic and genetic features of 24 colon cancer cell lines","volume":"2","author":"Ahmed","year":"2013","journal-title":"Oncogenesis"},{"key":"key20200713185904_b48-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccr.2008.02.003","article-title":"Yes and PI3K bind CD95 to signal invasion of glioblastoma","volume":"13","author":"Kleber","year":"2008","journal-title":"Cancer Cell"},{"key":"key20200713185904_b49-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/cdd.2015.25","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"22","author":"Peter","year":"2015","journal-title":"Cell Death Differ"},{"key":"key20200713185904_b50-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20200713185904_b51-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200713185904_b52-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clcc.2012.02.003","article-title":"Influence of KRAS p.G13D mutation in patients with metastatic colorectal cancer treated with cetuximab","volume":"11","author":"Gajate","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"key20200713185904_b53-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1158\/2159-8290.CD-14-0462","article-title":"Resistance to anti-EGFR therapy in colorectal cancer: From heterogeneity to convergent evolution","volume":"4","author":"Misale","year":"2014","journal-title":"Cancer Discov"},{"key":"key20200713185904_b54-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","article-title":"American Society of Clinical Oncology provisional clinical opinion: Testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy","volume":"27","author":"Allegra","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200713185904_b55-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1001\/jama.2010.1535","article-title":"Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab","volume":"304","author":"De Roock","year":"2010","journal-title":"JAMA"},{"key":"key20200713185904_b56-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1200\/JCO.2012.42.2592","article-title":"Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab","volume":"30","author":"Tejpar","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200713185904_b57-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1200\/JCO.2011.38.0915","article-title":"Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII study","volume":"30","author":"Tveit","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200713185904_b58-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/bjc.2017.93","article-title":"Cetuximab in treatment of metastatic colorectal cancer: Final survival analyses and extended RAS data from the NORDIC-VII study","volume":"116","author":"Guren","year":"2017","journal-title":"Br J Cancer"},{"key":"key20200713185904_b59-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/S0140-6736(11)60613-2","article-title":"MRC COIN Trial Investigators: Addition of cetuximab to oxali-platin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial","volume":"377","author":"Maughan","year":"2011","journal-title":"Lancet"},{"key":"key20200713185904_b60-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-14-1","article-title":"Overexpression of COX-2 mRNA in colorectal cancer","volume":"14","author":"Roelofs","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"key20200713185904_b61-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3892\/ol.2013.1426","article-title":"Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients","volume":"6","author":"Lin","year":"2013","journal-title":"Oncol Lett"},{"key":"key20200713185904_b62-ijo-55-01-0223","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.18632\/oncotarget.13990","article-title":"Clinicopathological and prognostic significance of COX-2 immu-nohistochemical expression in breast cancer: A meta-analysis","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185904_b63-ijo-55-01-0223","first-page":"364207","article-title":"Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: A meta-analysis","volume":"2014","author":"Wang","year":"2014","journal-title":"BioMed Res Int"},{"key":"key20200713185904_b64-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9","article-title":"Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398","volume":"86","author":"Elder","year":"2000","journal-title":"Int J Cancer"},{"key":"key20200713185904_b65-ijo-55-01-0223","first-page":"1088","article-title":"Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP","volume":"9","author":"Xu","year":"2017","journal-title":"Am J Transl Res"},{"key":"key20200713185904_b66-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","article-title":"Molecular targets of aspirin and cancer prevention","volume":"111","author":"Alfonso","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713185904_b67-ijo-55-01-0223","first-page":"383","article-title":"EGF stimulates cyclooxygenase-2 expression through the STAT5 signaling pathway in human lung adenocarcinoma A549 cells","volume":"39","author":"Cao","year":"2011","journal-title":"Int J Oncol"},{"key":"key20200713185904_b68-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1158\/1078-0432.CCR-05-1217","article-title":"Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways","volume":"11","author":"Lippman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20200713185904_b69-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1158\/1535-7163.MCT-04-0251","article-title":"Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer","volume":"4","author":"Choe","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20200713185904_b70-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"11777","DOI":"10.3748\/wjg.v21.i41.11777","article-title":"Pathophysiological mechanisms of death resistance in colorectal carcinoma","volume":"21","author":"Huang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20200713185904_b71-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1158\/1541-7786.MCR-09-0004","article-title":"Cyclooxygenase-2 (COX-2) negatively regulates expression of epidermal growth factor receptor and causes resistance to gefitinib in COX-2-overexpressing cancer cells","volume":"7","author":"Kim","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20200713185904_b72-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41598-017-00288-4","article-title":"Elevated COX-2 expression promotes angio-genesis through EGFR\/p38-MAPK\/Sp1-dependent signalling in pancreatic cancer","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"key20200713185904_b73-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/cdd.2014.216","article-title":"Old, new and emerging functions of caspases","volume":"22","author":"Shalini","year":"2015","journal-title":"Cell Death Differ"},{"key":"key20200713185904_b74-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.stem.2008.04.001","article-title":"Caspase activity mediates the differentiation of embryonic stem cells","volume":"2","author":"Fujita","year":"2008","journal-title":"Cell Stem Cell"},{"key":"key20200713185904_b75-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.stem.2008.03.012","article-title":"Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3","volume":"2","author":"Janzen","year":"2008","journal-title":"Cell Stem Cell"},{"key":"key20200713185904_b76-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"e2087","DOI":"10.1038\/cddis.2016.7","article-title":"Low levels of Caspase- 3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach","volume":"7","author":"Flanagan","year":"2016","journal-title":"Cell Death Dis"},{"key":"key20200713185904_b77-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1038\/sj.onc.1204815","article-title":"Apoptosis in the absence of caspase 3","volume":"20","author":"Liang","year":"2001","journal-title":"Oncogene"},{"key":"key20200713185904_b78-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","article-title":"Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy","volume":"17","author":"Huang","year":"2011","journal-title":"Nat Med"},{"key":"key20200713185904_b79-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"ra13","DOI":"10.1126\/scisignal.2000634","article-title":"Apoptotic cells activate the 'phoenix rising' pathway to promote wound healing and tissue regeneration","volume":"3","author":"Li","year":"2010","journal-title":"Sci Signal"},{"key":"key20200713185904_b80-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/ten.tec.2009.0247","article-title":"Mitochondrial function determines the viability and osteogenic potency of human mesenchymal stem cells","volume":"16","author":"Pietil\u00e4","year":"2010","journal-title":"Tissue Eng Part C Methods"},{"key":"key20200713185904_b81-ijo-55-01-0223","first-page":"6311","article-title":"The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis","volume":"63","author":"Heerdt","year":"2003","journal-title":"Cancer Res"},{"key":"key20200713185904_b82-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1158\/0008-5472.CAN-05-2444","article-title":"The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression","volume":"65","author":"Heerdt","year":"2005","journal-title":"Cancer Res"},{"key":"key20200713185904_b83-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1158\/0008-5472.CAN-05-2717","article-title":"Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential","volume":"66","author":"Heerdt","year":"2006","journal-title":"Cancer Res"},{"key":"key20200713185904_b84-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ijc.25944","article-title":"Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells","volume":"129","author":"Ye","year":"2011","journal-title":"Int J Cancer"},{"key":"key20200713185904_b85-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"31ra34","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci Transl Med"},{"key":"key20200713185904_b86-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.18632\/oncotarget.2010","article-title":"Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation","volume":"5","author":"Past\u00f2","year":"2014","journal-title":"Oncotarget"},{"key":"key20200713185904_b87-ijo-55-01-0223","doi-asserted-by":"crossref","first-page":"74781","DOI":"10.18632\/oncotarget.20367","article-title":"Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713185904_b88-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.bbamcr.2009.01.006","article-title":"Anti- and pro-tumor functions of autophagy","volume":"1793","author":"Morselli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20200713185904_b89-ijo-55-01-0223","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:05:02Z","timestamp":1594667102000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":89,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4809","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}